Despite the availability of cure for hepatitis C virus (HCV), people experiencing homelessness (PEH) are challenged with initiating and completing HCV treatment. The design of culturally sensitive HCV treatment programs is lacking. The objective was to employ community-based participatory research methods to understand perceptions of HCV-positive PEH, and providers, on the design and delivery of a culturally sensitive, nurse-led community health worker (RN/CHW) HCV initiation and completion program. Four focus group sessions were conducted with HCV-positive PEH (n = 30) as well as homeless service providers (HSP; n = 7) in Skid Row, Los Angeles. An iterative, thematic approach provided the themes of essentials of successful participant engagement and retention: Role of nurse-Led CHW in promoting: (a) tangible and emotional support; (b) cognitive and behavioral support; and (c) financial and structural resources. The goal of this study is to provide the groundwork for future research of HCV program design to support HCV cure among homeless populations.
AlaviM.PoustchiH.MeratS.Kaveh-eiS.Rahimi-MovagharA.ShadlooB.HajarizadehB.GrebelyJ.DoreG. J.MalekzadehR. (2019). An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE Study. International Journal of Drug Policy, 1(72), 99–105. https://doi.org/10.1016/j.drugpo.2019.07.002
3.
American Association of The Study of Liver Diseases and Infectious Diseases Society of American. (2019). Key populations: Identification and management of HCV in people who inject drugs. https://www.hcvguidelines.org/unique-populations/pwid
4.
AvramovicG.OpreaC.SureyJ.StoryA.MacíasJ.CullenW.IglesiasM.Mc HughT.CrowleyD.NaughtonA. M.HoranA. (2020). HepCare Europe: A service innovation project—HepCheck: Characteristics of the patient population with active infection as defined by HCV RNA. International Journal of Infectious Diseases, 91, 246–251. https://doi.org/10.1016/j.ijid.2019.11.027
5.
BassS. B.JessopA.MaurerL.GashatM.Al HajjiM.GutierrezM. (2018). Mapping the barriers and facilitators of HCV treatment initiation in methadone maintenance therapy patients: Implications for intervention development. Journal of Health Communication, 23(1), 117–127.
6.
BeijerU.WolfA.FazelS. (2012). Prevalence of tuberculosis, Hepatitis C Virus, and HIV in homeless people: A systematic review and meta-analysis. The Lancet Infectious Diseases, 12(11), 859–870.
7.
BenitezT. M.FernandoS. M.AminiC.SaabS. (2020). Geographically focused collocated Hepatitis C screening and treatment in Los Angeles’s Skid Row. Digestive Diseases and Sciences, 65(10), 3023–3031.
8.
BetancourtJ. R.GreenA. R.CarrilloJ. E.Ananeh-FirempongO. (2003). Defining cultural competence: A practical framework for addressing racial/ethnic disparities in health and health care. Public Health Reports, 118(4), 293–302. https://doi.org/10.1093/phr/118.4.293
9.
BrownM. A.GellatleyW.HoffmanA.DowdellL.CamacA.FrancoisR.BostonB.ZekryA. (2019). Medical complications of homelessness: A neglected side of men’s health. Internal Medicine Journal, 49(4), 455–460. https://doi.org/10.1111/imj.14139
ChildsE.AssoumouS. A.BielloK. B.BiancarelliD. L.DrainoniM. L.EdezaA.SalhaneyP.MimiagaM. J.BazziA. R. (2019). Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs. Harm Reduction Journal, 16(1), Article 14. https://doi.org/10.1186/s12954-019-0286-6
14.
DawM. A.DauA. A.AgnanM. M. (2012). Influence of healthcare-associated factors on the efficacy of Hepatitis C therapy. The Scientific World Journal, 2012, Article 580216.
DombrowskiK.SittnerK.CrawfordD.Welch-LazoritzM.HabeckerP.KhanB. (2016). Network approaches to substance use and HIV/Hepatitis C risk among homeless youth and adult women in the United States: A review. Health, 8(12), Article 1143. 10.4236/health.2016.812119
FokuoJ. K.MassonC. L.AndersonA.PowellJ.BushD.RiccoM.ZevinB.AyalaC.KhaliliM. (2020). Recommendations for implementing Hepatitis C Virus care in homeless shelters: The stakeholder perspective. Hepatology Communications, 4(5), 646–656.
19.
FreyB. B. (Ed.). (2018). The SAGE encyclopedia of educational research, measurement, and evaluation. SAGE.
20.
FusterD.GelbergL. (2019). Community screening, identification, and referral to primary care, for Hepatitis C, B, and HIV among homeless persons in Los Angeles. Journal of Community Health, 44(6), 1044–1054. https://link.springer.com/content/pdf/10.1007/s10900-019-00679-w.pdf
21.
GambleV. N. (1997). Under the shadow of Tuskegee: African Americans and health care. American Journal of Public Health, 87(11), 1773–1778. https://doi.org/10.2105/ajph.87.11.1773
22.
GaneE. (2020). Should we incentivize patients to take Hepatitis C Virus therapy?Clinical Dilemmas in Viral Liver Disease, 122–124.
23.
GelbergL.RobertsonM. J.AranguaL.LeakeB. D.SumnerG.MoeA.AndersenR. M.MorgensternH.NyamathiA. (2012). Prevalence, distribution, and correlates of Hepatitis C Virus infection among homeless adults in Los Angeles. Public Health Reports, 127(4), 407–421. https://doi.org/10.1177/003335491212700409
24.
GhoseT.ShubertV.PoitevienV.ChoudhuriS.GrossR. (2019). Effectiveness of a viral load suppression intervention for highly vulnerable people living with HIV. AIDS and Behavior, 23, 2443–2452. https://doi.org/10.1007/s10461-019-02509-5
25.
Gonzalez-GuardaR. M.JonesE. J.CohnE.GillespieG. L.BowenF. (2017). Advancing nursing science through community advisory boards: Working effectively across diverse communities. ANS: Advances in Nursing Science, 40(3), Article 278. https://doi.org/10.1097/ANS.0000000000000167
26.
GrebelyJ.DoreG. J.MorinS.RockstrohJ. K.KleinM. B. (2017). Elimination of HCV as a public health concern among people who inject drugs by 2030—What will it take to get there?Journal of the International AIDS Society, 20(1), Article 22146. https://doi.org/10.7448/IAS.20.1.22146
HanlonP.YeomanL.GibsonL.EsiovwaR.WilliamsonA. E.MairF. S.LowrieR. (2018). A systematic review of interventions by healthcare professionals to improve management of non-communicable diseases and communicable diseases requiring long-term care in adults who are homeless. British Medical Journal Open, 8(4), Article e020161. http://dx.doi.org/10.1136/bmjopen-2017-020161
29.
HarneyB. L.WhittonB.LimC.PaigeE.McDonaldB.NolanS.PembertonD.HellardM. E.DoyleJ. S. (2019). Quantitative evaluation of an integrated nurse model of care providing Hepatitis C treatment to people attending homeless services in Melbourne, Australia. International Journal of Drug Policy, 72, 195–198. https://doi.org/10.1016/j.drugpo.2019.02.012
30.
Henry-AkintobiT.LasterN.TrotterJ.JacobsD.JohnsonT.King GordonT.MillerA. (2016). The health, enlightenment, awareness, and living (HEAL) intervention: Outcome of an HIV and Hepatitis B and C risk reduction intervention. International Journal of Environmental Research and Public Health, 13(10), Article 948. https://doi.org/10.3390/ijerph13100948
31.
HenwoodB. F.LaheyJ.HarrisT.RhoadesH.WenzelS. L. (2018). Understanding risk environments in permanent supportive housing for formerly homeless adults. Qualitative Health Research, 28(13), 2011–2019. https://doi.org/10.1177/1049732318785355
HoS. B.BräuN.CheungR.LiuL.SanchezC.SklarM.PhelpsT. E.MarcusS. G.WasilM. M.TisiA.HuynhL.RobinsonS. K.GiffordA. L.AschS. M.GroesslE. J. (2015). Integrated care increases treatment and improves outcomes of patients with chronic Hepatitis C Virus infection and psychiatric illness or substance abuse. Clinical Gastroenterology and Hepatology, 13(11), 2005–14e143. https://doi.org/10.1016/j.cgh.2015.02.022
34.
HofmeisterM. G.RosenthalE. M.BarkerL. K.RosenbergE. S.BarrancoM. A.HallE. W.EdlinB. R.MerminJ.WardJ. W.RyersonA. B. (2019). Estimating prevalence of Hepatitis C Virus infection in the United States, 2013-2016. Hepatology, 69(3), 1020–1031. https://doi.org/10.1002/hep.30297
KermanN.SylvestreJ. (2020). Surviving versus living life: Capabilities and service use among adults with mental health problems and histories of homelessness. Health & Social Care in the Community, 28(2), 414–422. https://doi.org/10.1111/hsc.12873
38.
KohliA.OsinusiA.SimsZ.NelsonA.MeissnerE. G.BarrettL. L.BonD.MartiM. M.SilkR.KotbC.GrossC.JolleyT. A.SidharthanS.PetersenT.TownsendK.EgersonD.KapoorR.SpurlinE.SnellerM.. . . KottililS. (2015). Virological response after 6 week triple-drug regimens for Hepatitis C: A proof-of-concept phase 2A Cohort Study. Lancet, 385(9973), 1107–1113. https://doi.org/10.1016/S0140-6736(14)61228-9
39.
LambdinB. H.LorvickJ.MbwamboJ. K.RwegashaJ.HassanS.LumP.KralA. H. (2017). Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania. The International Journal on Drug Policy, 45, 64–69. https://doi.org/10.1016/j.drugpo.2017.05.043
40.
LambertJ. S.MurtaughR.MenezesD.O’CarrollA.MurphyC.CullenW.McHughT.AvramovicG.TinagoW.Van HoutM. C. (2019). HepCheck Dublin: An intensified Hepatitis C screening programme in a homeless population demonstrates the need for alternative models of care. BMC Infectious Diseases, 19(1), 1–9. https://doi.org/10.1186/s12879-019-3748-2J
MacLellanJ.SureyJ.AbubakarI.StaggH. R.MannellJ. (2017). Using peer advocates to improve access to services among hard-to-reach populations with Hepatitis C: A qualitative study of client and provider relationships. Harm Reduction Journal, 14(1), 1–9. https://doi.org/10.1186/s12954-017-0202-x
43.
MalespinM.HarrisC.KanarO.JackmanK.SmothermanC.JohnstonA.FermJ.de MeloJrScolapioJ. S.NelsonD. R.CotlerS. J. (2019). Barriers to treatment of chronic Hepatitis C with direct acting antivirals in an urban clinic. Annals of Hepatology, 18(2), 304–309.
44.
MassonC. L.FokuoJ. K.AndersonA.PowellJ.ZevinB.BushD.KhaliliM. (2020). Clients’ perceptions of barriers and facilitators to implementing Hepatitis C Virus care in homeless shelters. BMC Infectious Diseases, 20, 1–8.
Moore-NadlerM.ClantonC.RousselL. (2020). Storytelling to capture the health care perspective of people who are homeless. Qual Health Res, 30(2), 182–195. https://doi.org/10.1177/1049732319857058
47.
NguyenP.VutienP.HoangJ.TrinhS.LeA.YasukawaL. A.WeberS.HenryL.NguyenM. H. (2017). Barriers to care for chronic Hepatitis C in the direct-acting antiviral era: A single-centre experience. BMJ Open Gastroenterology, 4(1), Article e000181. https://doi.org/10.1136/bmjgast-2017-000181
48.
NyamathiA. M.SalemB. E.ZhangS.FarabeeD.HallB.KhalilifardF.LeakeB. (2015). Nursing case management, peer coaching, and Hepatitis A and B vaccine completion among homeless men recently released on parole: Randomized clinical trial. Nursing Research, 64(3), 177–189. https://doi.org/10.1097/NNR.0000000000000083
49.
NyamathiA. M.ShinS. S.SmeltzerJ.SalemB. E.YadavK.EkstrandM. L.TurnerS. F.FaucetteM. (2017). Achieving drug and alcohol abstinence among recently incarcerated homeless women: A randomized controlled trial comparing dialectical behavioral therapy-case management with a health promotion program. Nursing Research, 66(6), 432–441. https://doi.org/10.1097/NNR.0000000000000249
50.
NyamathiA. M.ShinS. S.SmeltzerJ.SalemB. E.YadavK.KroghD.EkstrandM. (2018). Effectiveness of dialectical behavioral therapy on reduction of recidivism among recently incarcerated homeless women: A pilot study. International Journal of Offender Therapy and Comparative Criminology, 62(15), 4796–4813. https://doi.org/10.1177/0306624X18785516
51.
O’SullivanM.JonesA. M.GageH.JordanJ.MacPeppleE.WilliamsH.VermaS. (2020). ITTREAT (Integrated Community Test-Stage-TREAT) Hepatitis C service for people who use drugs: Real-world outcomes. Liver International, 40(5), 1021–1031. https://doi.org/10.1111/liv.14403
52.
PahwaR.SmithM. E.YuanY.PadgettD. (2019). The ties that bind and unbound ties: Experiences of formerly homeless individuals in recovery from serious mental illness and substance use. Qualitative Health Research, 29(9), 1313–1323. https://doi.org/10.1177/1049732318814250
53.
PageK.YuM.CohenJ.EvansJ.ShumwayM.RileyE. D. (2017). HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, California. BMC Public Health, 17(1), Article 171. https://doi.org/10.1186/s12889-017-4102-5
54.
PhillipsC.SchulkindJ.O’SullivanM.EdelmanN.SmithH. E.VermaS.JonesC. J. (2020). Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT—An integrated community Hepatitis C service. Journal of Viral Hepatitis, 27(2), 176–187. https://doi.org/10.1111/jvh.13214
55.
RifaiM. A.MolesJ. K.ShortD. D. (2006). Hepatitis C treatment eligibility and outcomes among patients with psychiatric illness. Psychiatric Services, 57(4), 570–572. https://doi.org/10.1176/ps.2006.57.4.570
56.
Safreed-HarmonK.BlachS.AlemanS.BollerupS.CookeG.DalgardO.DillonJ. F.DoreG. J.DubergA. S.GrebelyJ.Boe KiellandK.MidgardH.PorterK.RazaviH.TyndallM.WeisN.LazarusJ. V. (2019). The consensus Hepatitis C cascade of care: Standardized reporting to monitor progress toward elimination. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 69(12), 2218–2227. https://doi.org/10.1093/cid/ciz714
57.
SaldañaJ. (2009). The coding manual for qualitative researchers. SAGE.
58.
SalemB. E.KlansekE.MoriskyD. E.ShinS. S.YadavK.ChangA. H.NyamathiA. M. (2020). Acceptability and feasibility of a nurse-led, community health worker partnered latent tuberculosis medication adherence model for homeless adults. International Journal of Environmental Research and Public Health, 17(22), Article 8342. https://doi.org/10.3390/ijerph17228342
59.
SalemB. E.KwonJ.EkstrandM. L.HallE.TurnerS. F.FaucetteM.SlaughterR. (2021). Transitioning into the community: Perceptions of barriers and facilitators experienced by formerly incarcerated, homeless women during reentry—A qualitative study. Community Mental Health Journal, 57(4): 609–621. https://doi.org/10.1007/s10597-020-00748-8
60.
SalemB. E.Ma-PhamJ.ChenS.BrechtM. L.AntonioA. L.AmesM. (2017). Impact of a community-based frailty intervention among middle-aged and older prefrail and frail homeless women: A pilot randomized controlled trial. Community Mental Health Journal, 53(6), 688–694. https://doi.org/10.1007/s10597-017-0147-2
61.
ShentonA. K. (2004). Strategies for ensuring trustworthiness in qualitative research projects. Education for Information, 22(2), 63–75. https://doi.org/10.3233/EFI-2004-22201
62.
SkeerM. R.LadinK.WilkinsL. E.LandyD. M.StopkaT. J. (2018). ‘Hep C’s like the common cold’: Understanding barriers along the HCV care continuum among young people who inject drugs. Drug and Alcohol Dependence, 190, 246–254. https://doi.org/10.1016/j.drugalcdep.2018.06.013
SureyJ.MenezesD.FrancisM.GibbonsJ.SultanB.MiahA.AbubakarI.StoryA. (2019). From peer-based to peer-led: Redefining the role of peers across the Hepatitis C care pathway: HepCare Europe. The Journal of Antimicrobial Chemotherapy, 74(5), 17–23. https://doi.org/10.1093/jac/dkz452
65.
SwanD.LongJ.CarrO.FlanaganJ.IrishH.KeatingS.KeaveneyM.LambertJ.McCormickP. A.McKiernanS.MoloneyJ.PerryN.CullenW. (2010). Barriers to and facilitators of Hepatitis C testing, management, and treatment among current and former injecting drug users: A qualitative exploration. AIDS Patient Care and STDs, 24(12), 753–762. http://dx.doi.org/10.1089/apc.2010.0142
66.
TatarM.KeeshinS. W.MailliardM.WilsonF. A. (2020). Cost-effectiveness of universal and targeted Hepatitis C Virus screening in the United States. JAMA Network Open, 3(9), Article e2015756. https://doi.org/10.1001/jamanetworkopen.2020.15756
67.
TongA.SainsburyP.CraigJ. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care, 19(6), 349–357. https://doi.org/10.1093/intqhc/mzm042
68.
TreloarC.RanceJ.BackmundM. (2013). Understanding barriers to Hepatitis C Virus care and stigmatization from a social perspective. Clinical Infectious Diseases, 57(Suppl. 2), S51–S55.
69.
Union Rescue Mission (URM, 2021). How We Help. Retrived from https://urm.org/services/ (accessed on June 14, 2021).
WerbD.GarfeinR.KerrT.DavidsonP.RouxP.Jauffret-RoustideM.AuriacombeM.SmallW.StrathdeeS. A. (2016). A socio-structural approach to preventing injection drug use initiation: Rationale for the PRIMER Study. Harm Reduction Journal, 13(1), 1–10. https://doi.org/10.1186/s12954-016-0114-1
72.
WilliamsB. E.NelonsD.SeamanA.WitkowskaM.RonanW.WheelockH.ZamanA.GarciaJ. (2019). Life projects: The transformative potential of direct-acting antiviral treatment for Hepatitis C among people who inject drugs. International Journal of Drug Policy, 72, 138–145. https://doi.org/10.1016/j.drugpo.2019.03.015
73.
WohlD. A.AllmonA. G.EvonD.HurtC.ReifeisS. A.ThirumurthyH.StraubB.EdwardsA.MollanK. R. (2017). Financial incentives for adherence to hepatitis C virus clinical care and treatment: A randomized trial of two strategies. Open Forum Infectious Diseases, 4(2), ofx095. https://doi.org/10.1093/ofid/ofx095
74.
ZhangS. X.ShoptawS.RebackC. J.YadavK.NyamathiA. M. (2018). Cost-effective way to reduce stimulant-abuse among gay/bisexual men and transgender women: A randomized clinical trial with a cost comparison. Public Health, 154, 151–160. https://doi.org/10.1016/j.puhe.2017.10.024
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
